TWIN FOCUS CAPITAL PARTNERS, LLC
Position in RNAC — Cartesian Therapeutics, Inc.
CIK 1387761
Boston, MA
Position in RNAC
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$260,500
+$140,575 QoQ
Shares Held
25,000
+28.2% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#36
of 95 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWIN FOCUS CAPITAL PARTNERS, LLC holds $24,101,992 across 3 Biotechnology names. RNAC ranks #3 (1.1% of the industry book) .
All Filings in RNAC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $260,500 | 25,000 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $119,925 | 19,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $140,595 | 19,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $199,290 | 19,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $197,410 | 19,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $197,700 | 15,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $214,920 | 12,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $193,440 | 12,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $270,100 | 10,000 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||